The shift toward self-administered therapies necessitates that pharmaceutical companies integrate patient onboarding, device training, and ongoing engagement into a seamless, unified journey. Prioritizing the patient voice as a "North Star" allows organizations to identify specific pain points and avoid the pitfalls of a fragmented, "kitchen sink" approach that often leads to patient confusion and treatment abandonment. Adam Shain, Vice President at Noble, emphasizes that success hinges on understanding the patient experience before implementing solutions, as the initial "day one" interaction with a device is critical for building long-term confidence and adherence. By consolidating disparate vendors and focusing on user-centric design, companies can effectively support patients from their first dose through long-term therapy, ensuring that complex self-injection systems are manageable and effective for diverse patient populations.
Sign in to continue reading, translating and more.
Open full episode in Podwise
